BioSig Enters into an LOI to Merge with Streamex Exchange Corp.

Core Insights - BioSig Technologies, Inc. has entered into a Letter of Intent for a proposed merger with Streamex Exchange Corporation in an all-stock transaction [1] - The merger is viewed as a transformative opportunity that will unlock significant growth potential and enhance market reach for both companies [2] Proposed Terms of Merger - Post-merger, current stockholders of Streamex will own approximately 19.9% of BioSig's outstanding Common Stock, and after the conversion of Preferred Stock, they will own about 75% of the outstanding Common Stock [5] Management Changes - Henry McPhie, Co-Founder and CEO of Streamex, will become the new CEO of BioSig, while Morgan Lekstrom, Co-Founder and Chairman of Streamex, will serve as Chairman of the Board [6] - Anthony Amato, the current CEO and Chairman of BioSig, will remain on the Board [6] Strategic Advisor Additions - Frank Giustra will join as a Strategic Investor and Advisor on Commodities, with a notable background in founding major companies [6] - Mathew August and Mitchell Williams will serve as Strategic Advisors on US Capital Markets, bringing extensive experience in investment and venture capital [6]